Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide

Neuroscience

Volumn 92, Issue 4, 1999, Pages 1465-1474

  Noda, M ^a   Nakanishi, H ^b   Akaike, N ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid peptide; Glutamate concentration; Glutamate transporter; Microglia; Patch clamp

Indexed keywords

3 HYDROXYASPARTIC ACID; AMYLOID BETA PROTEIN; GLUTAMIC ACID; KAINIC ACID; POTASSIUM; SODIUM;

ALZHEIMER DISEASE; AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MEMBRANE CURRENT; MICROGLIA; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

AMINO ACID TRANSPORT SYSTEM X-AG; AMYLOID BETA-PROTEIN; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; ELECTROPHYSIOLOGY; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; MICROGLIA; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; RATS; SODIUM; STIMULATION, CHEMICAL;

EID: 0033006151     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00036-6     Document Type: Article

References (36)

1. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14:1994;5559-5569.
2. Bannai S., Ishii T. A novel function of glutamine in cell culture: utilization of glutamine for the uptake of cystine in human fibroblasts. Cell Physiol. 137:1998;360-366.
3. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 388:1997;878-881.
4. Bouvier M., Szatkowski M., Amato A., Attwell D. The glial cell glutamate uptake carrier countertransports pH-changing anions. Nature. 360:1992;471-474.
5. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 382:1996;716-719.
6. Furukawa K., Abe Y., Akaike N. Amyloid β protein-induced irreversible current in rat cortical neurons. NeuroReport. 5:1994;2016-2018.
7. Giulian D., Haverkamp L.J., Yu J.H., Karshin W., Tom D., Li J., Kirkpatrick J., Kuo L.M., Roher A.E. Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16:1996;6021-6037.
8. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
9. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J. Neurochem. 76:1996;277-286.
10. Kanai Y., Nussberger S., Romero M.F., Boron W.F., Hebert S.C., Hediger M.A. Electrogenic properties of the epithelial and neuronal high affinity glutamate transporter. J. biol. Chem. 270:1995;16561-16568.
11. Koh J.-Y., Yang L.L., Cotman C.W. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:1990;315-320.
12. Kondo K., Hashimoto H., Kitanaka J., Sawada M., Suzumura A., Marunouchi T., Baba A. Expression of glutamate transporters in cultured glial cells. Neurosci. Lett. 188:1995;140-142.
13. Lendon C.L., Ashall F., Goate A.M. Exploring the etiology of Alzheimer disease using molecular genetics. J. Am. med. Ass. 277:1997;825-831.
14. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
15. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
16. Meda L., Cassarella M.A., Szendrei G.I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by β-amyloid protein and interferon-γ Nature. 374:1995;647-650.
17. Min B.I., Kim C.J., Rhee J.S., Akaike N. Modulation of glycine-induced chloride current in acutely dissociated rat periaqueductal gray neurons by μ-opioid agonist DAGO. Brain Res. 734:1996;72-78.
18. + channels in transformed NL308 neuroblastoma×fibroblast hybrid cells. Proc. R. Soc. Lond. B. 251:1993;215-224.
19. Patrizio M., Levi G. Glutamate production by cultured microglia: differences between rat and mouse, enhancement by lipopolysaccharide and lack of effect of HIV coat protein gp120 and depolarizing agents. Neurosci. Lett. 178:1994;184-188.
20. c in the macrophage-induced glutamate-dependent cytotoxicity to neurons J. Immun. 152:1994;3578-3585.
21. Piani D., Frei K., Do K.Q., Cuénod M., Fontana A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133:1991;159-162.
22. Pike C.J., Burdick D., Walencewics A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
23. Pines G., Danbolt N.C., Bjøras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B.I. Cloning and expression of a rat brain L-glutamate transporter. Nature. 360:1992;464-467.
24. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristrol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welthy D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 16:1996;675-686.
25. Sastradipura D.F., Nakanishi H., Tsukuba T., Nishishita K., Sakai H., Kato Y., Gotow T., Uchiyama Y., Yamamoto K. Identification of cellular compartments involved in processing of cathepsin E in primary cultures of rat microglia. J. Neurochem. 70:1998;2045-2056.
26. + current of Müller glial cells. Neuron. 10:1993;1141-1149.
27. Schwartz E.A., Tachibana M. Electrophysiology of glutamate and sodium co-transport in a glial cell of the salamander retina. J. Physiol., Lond. 426:1990;43-80.
28. Selkoe D.J. Alzheimer's disease: a central role for amyloid. J. Neuropath. exp. Neurol. 53:1994;438-447.
29. +-dependent glutamate/aspartate transporter from rat brain. Proc. natn. Acad. Sci. U.S.A. 89:1992;10955-10959.
30. Szatkowski M.B., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature. 348:1990;443-446.
31. Trotti D., Rizzini B.L., Rosii D., Haugeto O., Racagni G., Danbolt N.C., Volterra A. Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism. Eur. J. Pharmac. 9:1997;1236-1243.
32. Wyss-Coray T., Masliah E., Mallory M., McConlogue L., Johnson-Wood K., Lin C., Mucke L. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature. 389:1997;603-606.
33. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
34. Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F., Collison K., Zhu A., Stern E., Saido T., Tohyama M., Ogawa S., Roher A., Stern D. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature. 389:1997;689-695.
35. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
36. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.